ENDOCARDIAL FIBROSIS side effect
What is ENDOCARDIAL FIBROSIS ?
Help Community - Describe Your Side Effect
Search FDA Side Effects
Ask Health Expert
ENDOCARDIAL FIBROSIS and Recently Reported Side Effects
ENDOCARDIAL FIBROSIS and 15 most Active Side Effect polls
ENDOCARDIAL FIBROSIS and featured health surveys
Substances toxic to Health
Recent Hospital reviews
Comments about Side Effects
Hospital Quality reviews
Homecare Quality reviews
Mitoxantrone Side Effects Report #5427706-X
Consumer or non-health professional from GERMANY reported MITOXANTRONE problem on Aug 15, 2007. Male patient, 58 years of age, was diagnosed with encephalitis and was treated with MITOXANTRONE. After drug was administered, patient experienced the following problems/side effects: ejection fraction decreased, endocardial fibrosis, ventricular hypokinesia, . MITOXANTRONE dosage: 23 MG, 3 CYCLE, INTRAVENOUS (NOT OTHERWISE SPECIFIED). Patient recovered.
Mitoxantrone Side Effects Report #5382147-9
MITOXANTRONE problem was reported by a Health Professional from GERMANY on June 19, 2007. Female patient was treated with MITOXANTRONE. After drug was administered, patient experienced the following problems/side effects: ejection fraction decreased, endocardial fibrosis, ventricular hypokinesia, . MITOXANTRONE dosage: 23 MG, 3 CYCLE, IV (NOT OTHERWISE SPECIFIED). Patient recovered.
Mitoxantrone Side Effects Report #5388462-7
Consumer or non-health professional from UNITED STATES reported MITOXANTRONE problem on June 29, 2007. Female patient was treated with MITOXANTRONE. After drug was administered, patient experienced the following problems/side effects: ejection fraction decreased, endocardial fibrosis, ventricular hypokinesia, . MITOXANTRONE dosage: 23 MG, 3 CYCLE, INTRAVENOUS (NOT OTHERWISE SPECIFIED). Patient recovered.
Mitoxantrone Side Effects Report #5382147-9
MITOXANTRONE problem was reported by a Health Professional from GERMANY on June 19, 2007. Female patient was treated with MITOXANTRONE. After drug was administered, patient experienced the following problems/side effects: ejection fraction decreased, endocardial fibrosis, ventricular hypokinesia, . MITOXANTRONE dosage: 23 MG, 3 CYCLE, IV (NOT OTHERWISE SPECIFIED). Patient recovered.
Mitoxantrone Side Effects Report #5388462-7
Consumer or non-health professional from UNITED STATES reported MITOXANTRONE problem on June 29, 2007. Female patient was treated with MITOXANTRONE. After drug was administered, patient experienced the following problems/side effects: ejection fraction decreased, endocardial fibrosis, ventricular hypokinesia, . MITOXANTRONE dosage: 23 MG, 3 CYCLE, INTRAVENOUS (NOT OTHERWISE SPECIFIED). Patient recovered.
Magnevist Side Effects Report #5779183-7
MAGNEVIST problem was reported by a Consumer or non-health professional from UNITED STATES on June 06, 2008. Male patient, child 11 years of age, weighting 77.16 lb, was diagnosed with nuclear magnetic resonance imaging and was treated with MAGNEVIST. After drug was administered, patient experienced the following problems/side effects: cardiac arrest, endocardial fibrosis, joint contracture, metaplasia, mobility decreased, muscle contracture, myocardial fibrosis, nephrogenic systemic fibrosis, . MAGNEVIST dosage: TOTAL DAILY DOSE: 10 ML. During the same period patient was treated with OMNISCAN. Patient was hospitalized and became disabled. Patient died on 01/17/2005.
Magnevist Side Effects Report #5781498-3
Consumer or non-health professional from UNITED STATES reported MAGNEVIST problem on June 06, 2008. Male patient, child 11 years of age, weighting 77.16 lb, was diagnosed with nuclear magnetic resonance imaging and was treated with MAGNEVIST. After drug was administered, patient experienced the following problems/side effects: cardiac arrest, endocardial fibrosis, joint contracture, metaplasia, mobility decreased, muscle contracture, myocardial fibrosis, nephrogenic systemic fibrosis, . MAGNEVIST dosage: TOTAL DAILY DOSE: 10 ML. During the same period patient was treated with OMNISCAN. Patient was hospitalized and became disabled. Patient died on 01/17/2005.